<DOC>
	<DOCNO>NCT01423253</DOCNO>
	<brief_summary>Lurasidone HCl compound candidate treatment major depressive mix features.This clinical study design test well Lurasidone work treat major depressive disorder mixed feature time .</brief_summary>
	<brief_title>Major Depressive Disorder With Mixed Features - Extension</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<mesh_term>Lurasidone Hydrochloride</mesh_term>
	<criteria>Subject provide write informed consent willing able comply protocol opinion Investigator . Subject complete 6 week treatment Study D1050304 ( NCT # 01421134 ) Study D1050305 ( NCT # 01423240 ) . Subject judge Investigator suitable participation 12week clinical trial involve openlabel lurasidone treatment able comply protocol opinion Investigator . Subject answer `` yes '' `` Suicidal Ideation '' Item 4 5 CSSRS ( time evaluation ) baseline ( Day 43 Study D1050304 D1050305 ) . Subject consider Investigator imminent risk suicide injury self , others , property .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>Depression</keyword>
	<keyword>Lurasidone</keyword>
	<keyword>Latuda</keyword>
</DOC>